OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
115
Results
Show all
Save search
Copy query
Show results for
Unknown
(87)
Transcriptomics
(18)
Genomics
(7)
Other
(2)
Proteomics
(1)
Organisms
Homo sapiens
(8)
Rattus norvegicus
(7)
Mus musculus
(5)
Saccharomyces cerevisiae
(4)
Alphavirus
(1)
Anemia
(1)
Archaea
(1)
Bacteria
(1)
Betaherpesvirinae
(1)
Borrelia
(1)
Chlamydomonas reinhardtii
(1)
Clostridium perfringens
(1)
Dengue virus
(1)
Eukaryota
(1)
Hepatitis B virus
(1)
Human alphaherpesvirus 1
(1)
Human betaherpesvirus 5
(1)
Human immunodeficiency virus
(1)
Influenza A virus
(1)
Influenza C virus
(1)
Japanese encephalitis virus group
(1)
Kamptonema sp.
(1)
Listeria monocytogenes
(1)
Mammarenavirus
(1)
Miscanthus x giganteus
(1)
Mycobacterium tuberculosis
(1)
Orthoflavivirus
(1)
Pseudomonas aeruginosa
(1)
Rattus
(1)
Sarbecovirus
(1)
Organisms
Mus musculus
(2)
Repository
biostudies-arrayexpress
(21)
ENA
(3)
geo
(2)
EGA
(1)
pride
(1)
Tissue
Cell culture
(1)
Technology Type
Affinity purification coupled with mass spectrometry proteomics
(1)
Mass Spectrometry
(1)
Shotgun proteomics
(1)
Publication Date
2014
(6)
2013
(5)
2011
(3)
2010
(3)
2008
(2)
2022
(2)
2012
(1)
2009
(1)
2018
(1)
First Public Date
2022
(3)
Study type
Transcription profiling by array
(12)
RNA-seq of coding RNA
(5)
ChIP-seq
(3)
Comparative genomic hybridization by array
(1)
Release Date
2014
(13)
2023
(9)
2016
(8)
2019
(7)
2025
(6)
2021
(6)
2018
(6)
2015
(6)
2013
(5)
2011
(5)
2010
(5)
2008
(5)
2024
(5)
2017
(5)
2020
(4)
2012
(3)
2009
(3)
2022
(3)
2004
(2)
2007
(1)
2001
(1)
Lab affiliation
Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, 0379 Oslo, Norway
(1)
Tags
xref:PubMed:36599300
(2)
xref:PubMed:37874679
(2)
Previous
page
1 / 12
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
12
Next
page
Sort
by:
Relevance
Page size
10
Preclinical Evaluation of the Pan-FGFR Inhibitor LY2874455 in FRS2-Amplified Liposarcoma.
Not available
S-EPMC6406403
|
biostudies-literature
Cite
The Tyrosine Kinase Adaptor Protein FRS2 Is Oncogenic and Amplified in High-Grade Serous Ovarian Cancer.
Not available
S-EPMC4369154
|
biostudies-literature
Cite
Discovery of a small molecule ligand of FRS2 that inhibits invasion and tumor growth.
Not available
S-EPMC10060354
|
biostudies-literature
Cite
FRS2-independent GRB2 interaction with FGFR2 is not required for embryonic development.
Not available
S-EPMC10399203
|
biostudies-literature
Cite
Oncogenic and Immunological Roles of FRS2 and its Potential Value in Retroperitoneal Liposarcoma: from Bioinformatics Analysis to Clinicopathological Evidence.
Not available
S-EPMC11983304
|
biostudies-literature
Cite
Droplet digital PCR assay for precise determination of FRS2 gene copy number in bladder cancer.
Not available
S-EPMC12291395
|
biostudies-literature
Cite
Shc1 cooperates with Frs2 and Shp2 to recruit Grb2 in FGF-induced lens development.
Not available
S-EPMC11527007
|
biostudies-literature
Cite
Shc1 cooperates with Frs2 and Shp2 to recruit Grb2 in FGF-induced lens development.
Not available
S-EPMC12055001
|
biostudies-literature
Cite
Whole-genome sequencing identifies ADGRG6 enhancer mutations and FRS2 duplications as angiogenesis-related drivers in bladder cancer.
Not available
S-EPMC6372626
|
biostudies-literature
Cite
Xenopus FRS2 is involved in early embryogenesis in cooperation with the Src family kinase Laloo.
Not available
S-EPMC1083989
|
biostudies-literature
Cite
Previous
page
1 / 12
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
12
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
